1.
Emmanuelle Bouvet, Cécile Borel, Lucie Obéric, Gisèle Compaci, Bruno Cazin, Anne-Sophie Michallet, Guy Laurent, Loic Ysebaert. Impact of dose intensity on outcome of fludarabine, cyclophosphamide, and rituximab regimen given in the first-line therapy for chronic lymphocytic leukemia. haematol [Internet]. 2012Dec.31 [cited 2024Nov.25];98(1):65-0. Available from: https://haematologica.org/article/view/6537